Subject: RE: Request from MoH Georgia regarding procuring Remdesivir
From: Gaurav Joshi <[email-masked]>
To: "[email-masked]" <[email-masked]>
Cc: Satish Vijaywargi <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>
Date: Fri, 23 Oct 2020 12:17:25 +0000

Dear Maia Nikoleishvili MPA,

Greetings!!

Trust things are fine at your end!

With reference to below email and subsequent discussion over the telephone a week before regarding the understanding the requirements of the Remdesivir Injection
(Remdac).

During the telecon you have mentioned that one of our colleague has already responded over the email with commercial proposal.

Kindly be informed that we already have local partner “Bliss International (FZE)” to whom we have association for Zydus range of products including the Remdesivir
which we had supplied to them already in recent past and they will be in contact with you for the necessary availability of the product for the people of Georgia, following is the contact details and the email is also marked copy to Mr Satish.

Name                    : Mr Satish Vijaywargi

Email ID               :
[email-masked]

Mobile No          : 998903284805

We will remain at your disposal if any other information is requires from our side.

With Best Regards,

Gaurav Joshi

Business Development – Emerging Markets

Cadila Healthcare Ltd

Direct Phone: +91 79 71800 789/+91 79 48040 789

Mobile No    : +91-76000 94716

-------- Original message --------

From: Maia Nikoleishvili <[email-masked]>

Date: 10/10/2020 22:45 (GMT+05:30)

To: Amrut Medhekar <[email-masked]>, Ashish Trivedi <[email-masked]>, Ganesh Nayak <[email-masked]>,
Kumar K Singh <[email-masked]>

Cc: Tamar Gabunia <[email-masked]>, Archil Dzuliashvili <[email-masked]>

Subject: [EXTERNAL] Request from MoH Georgia regarding procuring Remdesivir

Dear Sirs,

I would like to kindly address you from the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health
and Social Affairs of Georgia regarding procuring generic form of Remdesivir manufactured by the Cadila Healthcare Limited under a license from Gilead Science Inc.

Considering current epidemiological situation, we are committed to use all existing opportunities, including engagement in the study
of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19 in order to avoid fatal outcomes in the infected patients as far as possible.

Therefore, we urgently need to procurer  Remdesivir, initially sufficient for 500 eligible patients and kindly request you to provide
us with the product price as well as terms and conditions of delivery as early as possible.

We rely on your support and do hope that our cooperation will be fruitful and successful.

Looking forward to receiving your feedback as soon as possible.

Sincerely yours,

Maia Nikoleishvili MPA

Head of International Relations and Protocol Division

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail:
[email-masked]

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the
designated recipient(s). If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality.
You are hereby notified that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any
attachment(s) to this electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take
no action.

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the
designated recipient(s). If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality.
You are hereby notified that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any
attachment(s) to this electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take
no action.

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the
designated recipient(s). If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality.
You are hereby notified that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any
attachment(s) to this electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take
no action.

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the designated recipient(s).
If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality. You are hereby notified
that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any attachment(s) to this
electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take no action.